Terms: = Colorectal cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
11 results:
1. Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma.
Patra R; Dey AK; Mukherjee S
PLoS One; 2023; 18(8):e0289064. PubMed ID: 37535606
[TBL] [Abstract] [Full Text] [Related]
2. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
Cheraghi-Shavi T; Jalal R; Minuchehr Z
PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
[TBL] [Abstract] [Full Text] [Related]
3. Optimizing Screening for colorectal cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
Petersen MM; Kleif J; Jørgensen LN; Hendel JW; Seidelin JB; Madsen MR; Vilandt J; Brandsborg S; Rasmussen JS; Andersen LM; Khalid A; Ferm L; Gawel SH; Martens F; Andersen B; Rasmussen M; Davis GJ; Christensen IJ; Therkildsen C
Clin Colorectal Cancer; 2023 Jun; 22(2):199-210. PubMed ID: 36878807
[TBL] [Abstract] [Full Text] [Related]
4. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract] [Full Text] [Related]
5. Minilaparotomy, Cyfra21-1, and Other Predicting Factors for Suboptimal Cytoreductive Surgery in Advanced Epithelial Ovarian cancer: A Pilot Study.
Nantasupha C; Pojchamarnwiputh S; Charoenkwan K
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4119-4124. PubMed ID: 36579993
[TBL] [Abstract] [Full Text] [Related]
6. Early detection of colorectal neoplasia: application of a blood-based serological protein test on subjects undergoing population-based screening.
Kleif J; Jørgensen LN; Hendel JW; Madsen MR; Vilandt J; Brandsborg S; Andersen LM; Khalid A; Ingeholm P; Ferm L; Davis GJ; Gawel SH; Martens F; Andersen B; Rasmussen M; Christensen IJ; Nielsen HJ
Br J Cancer; 2022 Jun; 126(10):1387-1393. PubMed ID: 35091694
[TBL] [Abstract] [Full Text] [Related]
7. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
8. Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.
Stiekema A; Van de Vijver KK; Boot H; Broeks A; Korse CM; van Driel WJ; Kenter GG; Lok CA
Cancer Cytopathol; 2017 Mar; 125(3):197-204. PubMed ID: 28199067
[TBL] [Abstract] [Full Text] [Related]
9. Potential role of he4 in multimodal screening for epithelial ovarian cancer.
Urban N; Thorpe JD; Bergan LA; Forrest RM; Kampani AV; Scholler N; O'Briant KC; Anderson GL; Cramer DW; Berg CD; McIntosh MW; Hartge P; Drescher CW
J Natl Cancer Inst; 2011 Nov; 103(21):1630-4. PubMed ID: 21917606
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Cramer DW; Bast RC; Berg CD; Diamandis EP; Godwin AK; Hartge P; Lokshin AE; Lu KH; McIntosh MW; Mor G; Patriotis C; Pinsky PF; Thornquist MD; Scholler N; Skates SJ; Sluss PM; Srivastava S; Ward DC; Zhang Z; Zhu CS; Urban N
Cancer Prev Res (Phila); 2011 Mar; 4(3):365-74. PubMed ID: 21372036
[TBL] [Abstract] [Full Text] [Related]
11. Development of a multimarker assay for early detection of ovarian cancer.
Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE
J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574
[TBL] [Abstract] [Full Text] [Related]
